Loading clinical trials...
Loading clinical trials...
VISmodegib for ORbital and Periocular Basal Cell Carcinoma (VISORB)
Conditions
Interventions
Vismodegib
Locations
1
United States
University of Michigan Hospital
Ann Arbor, Michigan, United States
Start Date
July 15, 2015
Primary Completion Date
September 1, 2020
Completion Date
September 1, 2020
Last Updated
October 28, 2021
NCT05955924
NCT01455363
NCT00218868
NCT04362722
NCT02310503
NCT04124796
Lead Sponsor
University of Michigan Rogel Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions